top of page
Browse by category
Search


REMAIN-1: Durable weight maintenance one year after GLP-1 discontinuation
Fractyl Health has announced positive one-year results from its REMAIN-1 Midpoint Cohort, reinforcing the potential of the Revita DMR System (Revita) to be the first durable procedural therapy for post-GLP-1 weight maintenance. The key findings include: Dose-dependent durability confirmed at one year: In the full modified intention-to-treat (mITT) population (N=45), a single Revita procedure reduced weight regain by approximately 40% versus sham at one year (least-squares mea


Weight loss drugs pose challenges for plastic surgeons
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons, according to a study from Duke University School of Medicine, which suggests that how much weight patients lose - and how fast - could affect surgical results to tighten or remove excess skin after massive weight loss. The study found that massive or rapid weight loss prior to abdominal body contouring surgery is predictive of postoperative


Joe Northup elected 40th President of ASMBS
Dr Joe Northup, Associate Professor of Surgery at Vanderbilt University School of Medicine and Director of Metabolic and Bariatric Surgery at Vanderbilt University Medical Center in Nashville, TN, has been elected the 40th president of the American Society for Metabolic and Bariatric Surgery (ASMBS), the nation’s largest professional organisation of metabolic and bariatric surgeons and integrated health professionals dedicated to the treatment of obesity and related diseases.


Most obesity drugs do not improve quality of life or heart health
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The British Medical Journal (BMJ). More weight loss is also generally accompanied by greater harms, including stomach and bowel symptoms, fatigue and loss of lean (muscle) mass, and improvements are not sustained after stopping treatment. Sever


Research reveals rise in US obesity rates
Obesity rates among US adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research led by the Johns Hopkins School of Medicine in Baltimore. Anum Minhas (Credit: Johns Hopkins School of Medicine) "Obesity is a leading public health concern, linked to higher risks for cardiovascular disease and premature death," said study author, Dr Anum Minhas, an assistant professor of med


MBS associated with favourable short‑ to mid‑term safety outcomes and improvements in weight and obesity‑related comorbidities in adolescents
Metabolic and bariatric surgery (MBS) can be delivered safely and effectively for adolescents and young adults living with severe obesity, offering promising improvements in weight loss and obesity-related health conditions, according to a study by researchers from LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute. The study examined outcomes from 76 patients ages 10–25 who underwent bariatric surgery
Browse by tag






bottom of page
